We investigated mechanisms of cell death during hypoxia/reoxygenation of cu
ltured kidney cells. During glucose-fret hypoxia, cell ATP levels declined
steeply resulting in the translocation of Bas from cytosol to mitochondria.
Concurrently, there was cytochrome c release and caspase activation. Cells
that leaked cytochrome c underwent apoptosis after reoxygenation, ATP depl
etion induced by a mitochondrial uncoupler resulted in similar alterations
even in the presence of oxygen. Moreover, inclusion of glucose during hypox
ia prevented protein translocations and reoxygenation injury by maintaining
intracellular ATP, Thus, ATP depletion, rather than hypoxia per se, was th
e cause of protein translocations. Overexpression of Bcl-2 prevented cytoch
rome c release and reoxygenation injury without ameliorating ATP depletion
or Bas translocation, On the other hand, caspase inhibitors did not prevent
protein translocations, but inhibited apoptosis during reoxygenation, Neve
rtheless, they could not confer long-term viability, since mitochondria had
been damaged. Omission of glucose during reoxygenation resulted in continu
ed failure of ATP production, and cell death,vith necrotic morphology. In c
ontrast, cells expressing Bcl-2 had functional mitochondria and remained vi
able during reoxygenation even,without glucose. Therefore, Bas translocatio
n during hypoxia is a molecular trigger for cell death during reoxygenation
. If ATP is available during reoxygenation, apoptosis develops; otherwise,
death occurs by necrosis. By preserving mitochondrial integrity, BCL-2 prev
ents both forms of cell death and ensures cell viability.